Comments on this technology were invited from clinical experts working in the field and relevant patient organisations. The comments received are individual opinions and do not represent NICE's view.
The following clinicians contributed to this briefing:
Professor Michael Clark, Professor in Tissue Viability – Birmingham City University; Director of the Welsh Wound Network, Commercial Director Welsh Wound Innovation Centre. Professor Clark consults for the Welsh Wound Innovation Centre, which does commercially funded research, and for several wound care companies. The Welsh Wound Innovation Centre has done research on behalf of Woundchek.
Mrs Caryn Carr, Lead Clinical Nurse Specialist in Tissue Viability – Southern Health NHS Foundation Trust. No conflicts of interest declared.
Mrs Fania Pagnamenta, Nurse Consultant (Tissue Viability) – The Newcastle upon Tyne Hospitals NHS Foundation Trust. No conflicts of interest declared.